Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From WuXi AppTec

Can BIOSECURE Maintain Its Virality In The TikTok Era?

With the sheen of inevitability now scuffed off the BIOSECURE Act, diplomatic efforts to reduce US dependence on Chinese APIs are increasing in prominence. And the power of the legislation itself could be determined by litigation about a video app.

China Supply Chain

US FDA Asked To Tighten China Risk Control By Legislators As Markup Looms

The proposed US BIOSECURE Act is heading to a full committee vote amid heightening tensions, underscored by new US Congressional Oversight Committee letters to the FDA asking it to examine national security threats posed by Chinese 'biotechs of concern.'

United States China

Supply Chain Derisking: The Case For US-India Partnering Amid China Clout

With just 14% of active pharmaceutical ingredients estimated to be made in the US and China’s overall dominance in the space, a new study points to the pressing need for the US to address bottlenecks in the supply chain and proposes a string of approaches to partner with India in its de-risking efforts.

Supply Chain Policy

Supply Chain Derisking: The Case For US-India Partnering Amid China Clout

With just 14% of active pharmaceutical ingredients estimated to be made in the US and China’s overall dominance in the space, a new study points to the pressing need for the US to address bottlenecks in the supply chain and proposes a string of approaches to partner with India in its de-risking efforts.

Policy Generic Drugs
See All

Company Information

  • Industry
  • Contract Research Organization-CRO
  • Laboratory Testing Services
  • Medical Devices
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Drug Discovery Technologies
      • ADMET
      • Bioinformatics
  • Other Names / Subsidiaries
    • Crelux GmbH
    • Faxian Therapeutics
    • JW Biotechnology (Shanghai) Co., Ltd
    • OXGENE
    • ResearchPoint Global
    • STA Pharmaceutical Co., Ltd.
    • WuXi PharmaTech
    • WuXi Merger Limited
    • XenoBiotic Laboratories, Inc.
UsernamePublicRestriction

Register